Roche: Change in treatment paradigm for nAMD with faricimab: Evidence from clinical trials and real-world practice
Location: Auditorium
Date & Time: Friday, 6 October, 13:45 - 14:45 CEST
Chairperson(s): Frank G. Holz GERMANY
Speakers:
Presentations:
F.G. Holz GERMANY
13:45 Welcome and opening remarks
M. Mohamed UK
13:55 Exploring first-line use with dual Ang-2/VEGF-A inhibition
G. Cheung SINGAPORE
14:10 Achieving rapid anatomical control
A. Khanani USA
14:25 Providing extended durability
F.G. Holz GERMANY
14:40 Closing remarks
